Medical Condition News

RSS

Waters recognizes Head of TGen's Center for Proteomics for research excellence

Waters Corporation today recognized the Center for Proteomics at the Translational Genomics Research Institute (TGen) as a Waters Center of Innovation.

26 Aug 2011

High job stress causes workers to increasingly seek help from health professionals

Job-related stress is catching up with the Canadians. A new study by Concordia University economists, published in BMC Public Health, has found that increased job stress causes workers to increasingly seek help from health professionals for physical, mental and emotional ailments linked to job stress.

26 Aug 2011

U.S. DoD awards $1.1M grant to Cleveland Clinic researcher for lupus research

The U.S. Department of Defense recently awarded a $1.1 million grant to a Cleveland Clinic researcher to investigate why females are disproportionately affected by lupus.

26 Aug 2011

Nasal spray with hot chili pepper ingredient may help people clear up sinus inflammation

Hot chili peppers are known to make people "tear up," but a new study led by University of Cincinnati allergy researcher Jonathan Bernstein, MD, found that a nasal spray containing an ingredient derived from hot chili peppers (Capsicum annum) may help people "clear up" certain types of sinus inflammation.

26 Aug 2011

Parkinson's important protein linked with fat metabolism

National Institutes of Health researchers have found that Parkin, an important protein linked with some cases of early-onset Parkinson's disease, regulates how cells in our bodies take up and process dietary fats.

26 Aug 2011

People with disabilities more likely to experience poorer health

Compared to racial and ethnic minority groups, people with disabilities are generally more likely to experience poorer health, according to a new report from the University of New Hampshire's Institute on Disability.

26 Aug 2011

Zinc may act as tumor suppressor in commonist form of pancreatic cancer

The essential element zinc has been shown in a new study to be a likely tumor suppressor in the commonist form of pancreatic cancer, University of Maryland scientists report in the current issue of the journal Cancer Biology & Therapy.

26 Aug 2011

Early-morning cigarette smokers more likely to develop lung, head and neck cancers

Two new studies have found that smokers who tend to take their first cigarette soon after they wake up in the morning may have a higher risk of developing lung and head and neck cancers than smokers who refrain from lighting up right away.

26 Aug 2011

Researchers reveal new gene associated with osteoarthritis

Researchers have today revealed a new gene associated with osteoarthritis. This is only the third gene to be identified for this painful and debilitating disease that affects more than 40 per cent of people aged more than 70 years.

26 Aug 2011

IOM issues new report on evidence and causality of vaccine harms

The Institute of Medicine's Panel on Adverse Effects of Vaccines issued a report today on the evidence and causality of vaccine harms. Despite a glowing press release, the report does little to allay public concerns over adverse effects of vaccines and suggests that we urgently need more science on vaccine adverse effects.

26 Aug 2011

Longer looks: Who is influencing health care?; Planned Parenthood's battle in the states; Oregon's new experiment

Right-wing radio host Rush Limbaugh once vowed to flee to Costa Rica if President Barack Obama's health care reforms took effect. Limbaugh might have overlooked a couple of critical details: Costa Rica's respected universal healthcare system is highly socialized. It's also on the verge of going broke. ... Costa Rica's broad coverage ranked better than most of the Americas, including the United States, in a 2000 World Health Organization index.

26 Aug 2011

Firazyr receives FDA approval for treatment of HAE acute attacks

The U.S. Food and Drug Administration today approved Firazyr (icatibant) Injection for the treatment of acute attacks of a rare condition called hereditary angioedema (HAE) in people ages 18 years and older.

26 Aug 2011

GCC hormone receptor may also help fight obesity

The hormone receptor guanylyl cyclase C (GCC) has been established as a suppressor of colorectal cancer tumors, but new evidence from Thomas Jefferson University suggests it may also help fight one of the country's biggest pandemics: obesity.

26 Aug 2011

FDA approves Avita's IDE for use of ReCell to treat hypertrophic dyspigmented scars

Avita Medical Ltd., the regenerative medicine company, today announced that the United States Food and Drug Administration (FDA) has approved the Company's investigational device exemption (IDE) feasibility study for the use of ReCell Spray-On-Skin in the treatment of hypertrophic dyspigmented scars: i.e., raised and/or discoloured scars.

26 Aug 2011

Omega-3s decreases severity of brain damage after stroke

A diet rich in omega-3s reduces the severity of brain damage after a stroke, according to a study conducted by Universit- Laval researchers. The team, co-directed by professors Jasna Kriz and Fr-d-ric Calon, showed that the extent of brain damage following a stroke was reduced by 25% in mice that consumed DHA type omega-3s daily.

26 Aug 2011

DaTscan allows doctors to differentiate Parkinson's from other movement disorders

Thanks to a new diagnostic imaging technique, physicians now have an objective test to evaluate patients for parkinsonian syndromes, such as Parkinson's disease. Northwestern Memorial Hospital is among the first institutions in the country to offer DaTscan-, the only FDA-approved imaging agent for assessment of movement disorders.

26 Aug 2011

Boehringer Ingelheim, Lilly receive EU approval for linagliptin to treat type 2 diabetes

Boehringer Ingelheim and Eli Lilly and Company today received Marketing Authorization from the European Commission for linagliptin 5 mg film-coated tablets for the treatment of adults with type 2 diabetes.

26 Aug 2011

Shire receives FDA marketing approval for FIRAZYR to treat acute attacks of HAE

Shire plc, the global specialty biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has granted marketing approval for FIRAZYR for treatment of acute attacks of hereditary angioedema (HAE) in adults 18 years of age and older.

26 Aug 2011

Allergan gets FDA nod for use of Botox in urinary incontinence

Allergan Inc. has received United States Food and Drug Administration (FDA) approval to market the wrinkle smoother Botox as a treatment for urinary incontinence. The FDA approved the drug for people with overactive bladders who have neurologic conditions such as multiple sclerosis and spinal cord injuries, the agency said today in a statement. The medicine is injected into the bladder to increase its capacity by relaxing muscles.

25 Aug 2011

Simcere receives Chinese SFDA approval for Iremod to treat active rheumatoid arthritis

Simcere Pharmaceutical Group, a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded generic and proprietary pharmaceuticals in China, today announced that it has received the new drug approval from the State Food and Drug Administration for Iremod.

25 Aug 2011

Medical Condition News

Waters recognizes Head of TGen's Center for Proteomics for research excellence

High job stress causes workers to increasingly seek help from health professionals

U.S. DoD awards $1.1M grant to Cleveland Clinic researcher for lupus research

Nasal spray with hot chili pepper ingredient may help people clear up sinus inflammation

Parkinson's important protein linked with fat metabolism

People with disabilities more likely to experience poorer health

Zinc may act as tumor suppressor in commonist form of pancreatic cancer

Early-morning cigarette smokers more likely to develop lung, head and neck cancers

Researchers reveal new gene associated with osteoarthritis

IOM issues new report on evidence and causality of vaccine harms

Longer looks: Who is influencing health care?; Planned Parenthood's battle in the states; Oregon's new experiment

Firazyr receives FDA approval for treatment of HAE acute attacks

GCC hormone receptor may also help fight obesity

FDA approves Avita's IDE for use of ReCell to treat hypertrophic dyspigmented scars

Omega-3s decreases severity of brain damage after stroke

DaTscan allows doctors to differentiate Parkinson's from other movement disorders

Boehringer Ingelheim, Lilly receive EU approval for linagliptin to treat type 2 diabetes

Shire receives FDA marketing approval for FIRAZYR to treat acute attacks of HAE

Allergan gets FDA nod for use of Botox in urinary incontinence

Simcere receives Chinese SFDA approval for Iremod to treat active rheumatoid arthritis

How can microdialysis benefit drug development

Global and Local Efforts to Take Action Against Hepatitis

Addressing Important Cardiac Biology Questions with Shotgun Top-Down Proteomics

Latest News